Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Observation on efficiency of Jiangtang (降糖) capsule in treating diabetes mellitus type 2 with hyperlipidemia

  • 21 Accesses

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Drug Affair Bureau, Ministry of Health. PRC technical guiding principle on clinical study of new Chinese drugs in treating DM (Xiaoke disease). J Chin Med Pharmacol 1989;5(4):76–78.

  2. 2.

    Diagnostic referential standard of blood stasis syndrome. Blood Stasis Syndrome Research International Conference. 1989;9(2):111–112.

  3. 3.

    Ministry of Health, PRC Guiding Principle of Drug Clinical Study (tentative) 1988:86–88.

  4. 4.

    WANG JH, LIU SR. Study on relationship of phlegm-turbid blood (hyperlipidemia) and hemorheology. Prac J Trad Chin West Med 1996;9(5):283.

Download references

Author information

Correspondence to Xiao-qiang Yin.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yin, X., Zhang, S., Kong, Y. et al. Observation on efficiency of Jiangtang (降糖) capsule in treating diabetes mellitus type 2 with hyperlipidemia. CJIM 7, 214 (2001). https://doi.org/10.1007/BF03178493

Download citation

Keywords

  • Gliclazid
  • Blood Stasis
  • Total Effective Rate
  • Blood Stasis Syndrome
  • Western Drug